跳至主要内容
临床试验/CTRI/2018/08/015207
CTRI/2018/08/015207尚未招募3 期

Efficacy of oral supplementation of emblica officinalis(amla)powder on systolic and diastolic blood pressure among hypertensive patients

MissKaruturi Harika0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients who are willing to participate
  • 2.Both males and females
  • 3.Diagnosed hypertensive patients of age group between 40-65yrs attending medicine OPD of kasturba hospital
  • 4.Cut off values for participants is above 120/80 mmHg

排除标准

  • 1.Age group below 40yrs and above 65yrs
  • 2.Pregnant and lactating women
  • 3.With any other comorbid conditions
  • 4.Patients that are immune compromised suffering from terminal illness like HIV,cancer or those who are under medical treatment
  • 5.Critical illness patients
  • 6.Diagnosed hypertensive patients of age group between 40-65yrs not attending medicine OPD of kasturba hospital

研究者

发起方
MissKaruturi Harika

相似试验